EDGAR Filing Documents for 0001693011-17-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001693011-17-000002

Filing Date

2017-01-05

Accepted

2017-01-05 16:21:10

Documents

Effectiveness Date

2017-01-05

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	5583
	Complete submission text file	0001693011-17-000002.txt		6593

Mailing Address 240 BLUFF VIEW DRIVE GUILFORD CT 06347

Business Address 240 BLUFF VIEW DRIVE GUILFORD CT 06347 2034423597

Inozyme Pharma, LLC (Filer) CIK: 0001693011 (see all company filings)